A twenty-year follow-up of canine leishmaniosis in three military kennels in southeastern France by Davoust, Bernard et al.
A twenty-year follow-up of canine leishmaniosis in three
military kennels in southeastern France
Bernard Davoust, Ce´dric Roqueplo, Daniel Parzy, Ste´phanie Watier-Grillot,
Jean-Lou Marie´
To cite this version:
Bernard Davoust, Ce´dric Roqueplo, Daniel Parzy, Ste´phanie Watier-Grillot, Jean-Lou Marie´. A
twenty-year follow-up of canine leishmaniosis in three military kennels in southeastern France.
Parasites and Vectors, BioMed Central, 2013, 6 (1), pp.323. <inserm-00905830>
HAL Id: inserm-00905830
http://www.hal.inserm.fr/inserm-00905830
Submitted on 18 Nov 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
Davoust et al. Parasites & Vectors 2013, 6:323
http://www.parasitesandvectors.com/content/6/1/323SHORT REPORT Open AccessA twenty-year follow-up of canine leishmaniosis
in three military kennels in southeastern France
Bernard Davoust1,2*, Cédric Roqueplo1, Daniel Parzy3,4, Stéphanie Watier-Grillot1 and Jean-Lou Marié1Abstract
Background: Canine leishmaniosis (CanL) is enzootic in southeastern France, and military working dogs (MWD)
posted in this area are highly exposed. To assess the efficiency of prevention, we performed a serological and
clinical follow-up of 80 MWD in the Var and Corsica regions during the 20-year period from 1993 to 2012. The
systematic and specific prevention of CanL using a deltamethrin-impregnated collar (DMC) was implemented in 2002.
Findings: Out of 80 dogs tested annually, the cumulative serological and clinical incidence was 42.5% (34/80) and
21.2% (17/80) respectively, during the first period, and these numbers decreased to 6.2% (5/80) and 2.5% (2/80) during
the second period (p < 0.00001). Considering the incidence of serology since 2002, the CanL risk has been reduced by
85.2% and the level of protection of MWD reached 93.8%. Dogs without collars had a 10.4-fold greater chance of
becoming infected than protected dogs. Although other ecological factors might have influenced the epidemiology of
CanL, DMC usage was the main factor affecting dog exposure to CanL.
Conclusions: The prevention strategy based on DMC proved highly efficient in our population of MWD, as it effectively
controlled the disease. This result is also of interest to public health, as dogs are reservoirs for Leishmania infantum.
Keywords: Canine leishmaniosis, Indirect fluorescent antibody test, Leishmania infantum, Seroprevalence, France,
Deltamethrin, DogFindings
Canine leishmaniosis (CanL), caused by the protozoan
Leishmania infantum Nicolle (family Trypanosomidae; class
Kinetoplastida), has a high incidence in all Mediterranean
regions and in many Latin American countries [1]. Dogs
are the main reservoir of the parasite that causes human
visceral leishmaniosis, a major zoonosis. Infection by
Leishmania is almost exclusively vectorial, via the
bite of female sandflies of the subgenus Phlebotomus
(Larroussus) [1]. In France, CanL is primarily located on
the Mediterranean coast but has expanded its distribution
area to the north and east. The most affected area is the
Andorra Nice-Lyon triangle [2]. Infections are seasonal,
occurring from spring to autumn. The control of CanL is
important for two reasons [3,4]. In the field of animal
health, CanL is clinically characterized by mucocutaneous* Correspondence: bernard.davoust@gmail.com
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stated.and visceral involvement, which gradually progresses
towards the death of the animal [5]. There is also a
public health issue. Traditionally affecting children, human
leishmaniosis has become an opportunistic infection of
immunocompromised adults [6]. Whilst treatments are
effective they are also long, stressful and rather toxic.
Consequently, exposed dogs must be treated with effective
prophylactic measures.
In 1993, CanL seroprevalence was assessed using
an indirect fluorescent antibody test (IFAT) in three
kennels of military working dogs (MWD) in southeastern
France. The cumulative seroprevalence was 11.6% (9/77),
including 22.7% (5/22) in Solenzara (Corsica) and 7.2%
(4/55) in Toulon/Hyères [7]. During the following 20 years,
preventive measures and monitoring of leishmaniosis
were implemented. The average global population was
80 dogs and yearly changes in the average were minor.
We included Belgian shepherd malinois (for the majority)
and German shepherd, males, aged 2–9 years, that
originated from countries non-endemic for leishmaniosis
(Belgium, Luxembourg, Netherlands and Germany). Since
2002, all MWD wore a 4% (40 mg/g) deltamethrin-l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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Figure 1 Incidence of leishmaniosis in a population of military dogs receiving a specific prevention (DMC) since 2002.
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Animal Health] upon their initial arrival into CanL-
enzootic areas. Collars were put in place each year in
April and withdrawn in October. The dogs were working
and living in three different military camps based near
three cities in southern France: Toulon (longitude: 5°55’E;
latitude: 43°10’N), Hyères (longitude: 06°09’E; latitude:
43°08’N) and Solenzara (longitude: 09°24’E; latitude:
41°55’N). Due to the proximity of Toulon and Hyères,
they were merged into one area (Var), and Solenzara
was considered a different area (Corsica). In addition,
MWD in Toulon and Hyères belong to the same military
unit and are regularly moved between kennels. These dogs
do not leave the Var region. However, dogs in Solenzara
have periodically completed short stays (four months)
in Africa, the Balkans, Central Asia or French Guiana.
All MWD were examined by veterinarians at least once
a year during the vaccination boost (rabies and DHLPP).
None of the MWD received vaccinations against CanL.
A clinical diagnosis of CanL was made in the presence
of the classical clinical signs (asthenia, weight loss,
squamosis, alopecia, onychogryphosis, lymphadenomegaly,
and nose .ulcers) associated with positive serology.
Clinically ill MWD received a specific treatment (me-
glumine antimoniate and allopurinol). Dogs that were
severely ill after treatments were euthanized.
At the beginning of each year, all dogs were subjected
to a serological test (IFAT), but excluding the years:
1994, 1997, 2003, 2009 and 2011. Blood samples from
the radial vein were centrifuged within 24 hours after





Toulon/Hyères 46 25 (54.3%)
Solenzara 34 9 (26.5%)
Total 80 34 (42.5%)the reference test, sensitive and specific [1,8,9]. The L.
infantum antigen (Synbiotics Laboratory, Lyon, France)
consisted of formalized promastigotes. The antigen was
added to immunofluorescent slides and fixed in cold
acetone for 20 min. The collected serum was pre-diluted
20-fold and examined with an ultraviolet microscope at
500X magnification. The presence of anti-Leishmania
antibodies was detected by promastigote fluorescence.
Negative sera were not fluorescent. Titers ≥ 1:100 were
considered positive, according to our laboratory reference.
The correlation between DMC treatment and CanL
incidence was evaluated with the Fischer test, the Mid-p
exact test and the linear correlation test (Pearson’s
coefficient) with a 95% significance level (p < 0.05) using
Epi InfoW and Open EpiW software.
The longitudinal follow-up results from the canine
population (average 80 MWD) are presented in Figure 1.
There was no specific prevention of CanL for 9 years
(1993–2001), and subsequently, DMC was used for 11 years
(2002–2012). During this 20-year period, the number
of MWD remained quite stable, but the individual dogs
changed (transfer, discharge, death). However, the new
replaced dogs were tested for CanL, and only seronegative
dogs were introduced. On average, MWD stayed 7 years
in the same kennel. In our study, all dogs with clinical
CanL were seropositive. The incidence of CanL-sero-
positive dogs is summarized in Table 1. There was a
significant difference between the period before 2002
(34 cases - 42.5%) and after 2002 (5 cases - 6.2%), although
the second period is 2 years longer. Considering the
incidence of positive serology since 2002, the CanL riskuse of DMC
dogs p-value Power of the test
2002-2012 (α = 0.05)
1 (2.1%) < 0.00001 100%
4 (11.8%) > 0.1 30%
5 (6.2%) < 0.00001 99.99%
Table 2 Incidence of morbidity due to CanL, before and after the use of DMC
Locations Number
of dogs
Symptomatic dogs p-value Power of the test
1993-2001 2002-2012 (α = 0.05)
Toulon/Hyères 46 10 (21.7%) 0 (0%) < 0.001 92%
Solenzara 34 7 (20.5%) 2 (5.9%) > 0.05 40%
Total 80 17 (21.2%) 2 (2.5%) < 0.0001 97%
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MWD were protected from disease. Based on the mean
annual incidence, the relative risk was 8.4, which means
that dogs without collars had an 8.4-fold greater chance
of becoming seropositive than dogs protected by collars.
Moreover, there was a significant difference in symptom-
atic dogs between these two periods: 17 clinical cases
before 2002 and 2 afterwards (Table 2). Dogs without
collars had a 10.4-fold greater chance of becoming clin-
ically ill than protected dogs. Based on these data, the
efficiency of prevention of clinical leishmaniosis was
88.2%. Due to a low number of dogs in Solenzara, the
statistical test failed to find a significant difference. For
both areas, half of the seropositive dogs were clinically
ill. IFAT serological titers were higher before 2002, with
15 of 34 dogs exhibiting a titer ≥ 1:1600, but due to a
low number of seropositive dogs after 2002, the difference
is not significant (p = 0,058) (Table 3).
We observed that wearing a DMC is significantly
associated with a reduction of CanL incidence, but we
could not conclude direct causality. In the absence of
data from dogs in southeastern France, we contacted
veterinary practices in Toulon, Hyères and Solenzara.
In these areas, the results were identical; the number of
CanL clinical cases had decreased, mainly since 2008.
This reduction is attributed to the most frequent use of
external antiparasitic products (personal communication).
Moreover, in 2007–2008, we screened MWD for Leish
mania using qPCR [10]. The prevalence was 66.6% (32/
48) in the Var region and 22.6% (7/31) in Corsica.
Deltamethrin acts on the nervous membranes of phle-
botomines, inducing a massive release of synaptic neuro-Table 3 Distribution of the serological titers









Total 34 5secretions and neurohormones. Both anti-feeding and
lethal effects are observed. Experimental trials have
demonstrated that topical insecticides and DMC, can
protect dogs from > 85% of sandfly bites for up to
6 months [11]. DMC reduces the contacts between
dogs and phlebotomines, thus protecting dogs and as a
result, humans, from visceral leishmaniosis.
Other studies have shown that DMC protects dogs
in the field. In Tunisia, the efficiency was 100% in 42
treated dogs compared with a control group [12]. Of
60 dogs followed for two years in Italy, the efficiency
was 51% [13]. In a study of 350 dogs in southern Italy,
the efficiency was 46% during the first year and 86% in
the second year [14]. This cumulative effect illustrates the
epidemiological impact of DMC on vectorial transmission.
In Brazil, 136 dogs were protected by DMC, resulting
in an efficiency of 50% during a one-year period [15].
In Italy, the risk of CanL was reduced by 84% using
DMC and also using a spot-on solution of permethrin [16].
In 2004, a spot-on treatment containing a combination of
10% imidacloprid and 50% permethrin was launched on
the French market for the prevention of CanL (AdvantixW,
Bayer Animal Health). In experimental conditions, this
spot-on has been successfully assessed to determine the
number of sandflies (dead and alive) after treatment
[17-19]. The results from field studies are also strongly
positive and similar to those obtained with DMC [20].
In Italy, the efficiency fluctuated between 84 and 100%
[16,21,22]. More recently, a collar with a combination of
10% imidacloprid and 4.5% flumethrin (SerestoW, Bayer
Animal Health) was 100% efficient in the field [23].
In France, the annual number of human cases of visceral
leishmaniosis (VL) reported to the national reference
center was roughly unchanged until 2007, after which
it decreased [24]. From 2001 to 2003, there were 66
human cases [8]. These cases mainly came from the
well-known foci of Côte d'Azur, Provence and Cévennes;
40% of the patients were co-infected with HIV. These
co-infections decreased after 2003 [24]. From 1999 to
2001 (3 years), 83 cases were reported, and there were
only 149 cases for the period 2002–2010 (9 years). The
difference between these 2 periods, which are included
in our study, is statistically significant (p < 0.001) [24].
Thus, human leishmaniosis is in regression in southeastern
France, due to lower infection pressure and fewer infected
reservoir dogs; the dogs being better protected by adequate
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treatments is an interesting alternative to culling, which
remains controversial [14,15].
Conclusions
Serological and clinical surveillance of CanL was carried
out in a population of 80 MWD during a 20-year period.
The decrease in the incidence rate of symptomatic and
asymptomatic cases is most likely multifactorial and related
to the use of DMC and/or environmental changes. When
preventive measures are not implemented, CanL rapidly
spreads in kennels [25]. External antiparasitic products
that are efficient against phlebotomines are essential for
MWD in areas of France or abroad that are endemic
for leishmaniosis. Vaccination should also be integrated
into the prevention strategy, if necessary, and following the
recommendations of experts [3,4]. Further epidemiological
studies are required to investigate additional potential
reservoirs (cats, horses, foxes, rodents), vector insecticide
resistance, and the behavior of phlebotomines feeding
on hosts.
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